Three-dimensional morphometric analysis for hepatectomy of centrally located hepatocellular carcinoma: A pilot study

Table 1 Patient and tumor characteristics n (%)

Variables	Value
Gender
Male	34 (87.1)
Female	5 (12.9)
Hepatitis B carrier	37 (94.8)
Hepatitis C carrier	2 (5.1)
ICG-R15	7.1% ± 5.9%
Pathologic characteristics
Fibrosis score F0	15 (38.4)
Fibrosis score F1	24 (61.5)
Tumor diameter (cm)	4.5 ± 2.1
Resection margin (mm)	9.1 ± 5.9
Vascular adhesion	11 (28.2)
Liver capsule invasion	24 (61.5)
Major vascular invasion	3 (7.7)
BCLC staging
Stage A	25 (64.1)
Stage B	11 (28.2)
Stage C	3 (7.7)
Surgical procedure
Hemi-hepatectomy	7 (17.9)
Mesohepatectomy	5 (12.8)
Segmentectomy	13 (33.3)
Irregular resection	14 (35.9)
Postoperative complications
Massive hemorrhage	2 (5.1)
Bile leakage	2 (5.1)
Massive ascites	3 (7.7)
Pleural effusion	1 (2.6)
Hospital mortality	0 (0.0)

Data are expressed as mean ± SD or n (%). BCLC: Barcelona Clinic Liver Cancer; ICG: Indocyanine green.